Leef Brands (LEEEF) EPS (Weighted Average and Diluted) (2025 - 2026)
Leef Brands' (LEEEF) quarterly EPS (Weighted Average and Diluted) came in at -$0.0 in Q1 2026, down 300.0% year-on-year from $0.0 in Q1 2025, and down 300.0% quarter-over-quarter from $0.0 in Q1 2025.
Leef Brands (LEEEF) EPS (Weighted Average and Diluted) (2025 - 2026) Analysis & Trends
Leef Brands has disclosed EPS (Weighted Average and Diluted) across 2 years of filings, most recently posting -$0.0 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.0, down 300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.0 (changed N/A YoY), and the FY2025 annual result was -$0.1, up 41.18% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.0 for Q1 2026 at Leef Brands, down from $0.0 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q1 2025 to a low of -$0.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Leef Brands | - | - | 4.62 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Mar 31, 2025 | 0.00 |